文献速递甲状腺疾病

Graves眼病机制:凋亡是胰岛素样生长因子1受体抑制的终点

Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
PubMed 文献 · Thyroid · 2022-01-01

本研究通过细胞实验探讨IGF-1R阻断抗体在Graves眼病中的作用机制。发现刺激型TSHR抗体可诱导IGF-1R磷酸化并启动TSHR和IGF-1R信号,而IGF-1R-B-mAb(1H7)抑制主要IGF-1R信号级联并减少TSHR信号,导致自噬抑制和凋亡性细胞死亡。

要点

  • 刺激型TSHR抗体可诱导小鼠和人成纤维细胞中IGF-1R磷酸化并启动TSHR和IGF-1R信号。
  • IGF-1R-B-mAb(1H7)抑制主要IGF-1R信号级联并减少TSHR信号。
  • 该抗体抑制自噬并诱导凋亡,可能为IGF-1R抑制减少突眼的主要机制。

核心结论

  • 刺激型TSHR抗体可增强IGF-1R活性并促进眶后细胞增殖和炎症。
  • IGF-1R-B-mAb可抑制IGF-1R信号,通过细胞外凋亡途径导致眶后成纤维细胞/脂肪细胞死亡。
  • 这可能是IGF-1R抑制治疗Graves眼病患者突眼减少的主要机制。

研究设计与样本

  • 采用Li-Cor In-Cell Western、Western blot和免疫组化检测小鼠和人成纤维细胞中不同蛋白水平。
  • 使用蛋白质组阵列定义通路信号分子。
  • 使用CCK-8和BrdU细胞增殖ELISA分析细胞对不同抗体的增殖反应。

主要发现

  • 刺激型TSHR抗体能够诱导小鼠和人成纤维细胞中IGF-1R的磷酸化,并启动TSHR和IGF-1R信号。
  • IGF-1R-B-mAb(1H7)抑制所有主要IGF-1R信号级联,并减少TSHR信号。
  • 该抗体抑制多种自噬相关蛋白(Beclin1、LC3a、LC3b、p62和ULK1),并诱导cleaved caspase 3、FADD和caspase 8激活,表明凋亡性细胞死亡。
  • 该IGF-1R阻断mAb抑制血清诱导的perkin和pink线粒体自噬蛋白。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Graves' eye disease, also called Graves' orbitopathy (GO), is a potentially debilitating autoimmune disease associated with retro-orbital inflammation and tissue expansion, involving both fibroblasts and adipocytes, resulting in periorbital edema, worsening proptosis, and muscle dysfunction with diplopia and may ultimately threaten sight. Accumulating evidence has indicated that autoantibodies to the thyrotropin receptor (TSHR), which induce the hyperthyroidism of Graves' disease, also help mediate the pathogenesis of the eye disease in susceptible individuals through TSHR expression on retro-orbital cells. Since it has long been known that the effects of insulin-like growth factor 1 (IGF-1) and thyrotropin are additive, recent clinical trials with a human monoclonal IGF-1 receptor blocking antibody (teprotumumab; IGF-1R-B-monoclonal antibody [mAb]) have demonstrated its ability to induce significant reductions in proptosis, diplopia, and clinical activity scores in patients with GO. However, the molecular mechanisms by which such an antibody achieves this result is unclear. Methods: We have used Li-Cor In-Cell Western, Western blot, and immunohistochemistry to define levels of different proteins in mouse and human fibroblast cells. Proteomic array was also used to define pathway signaling molecules. Using CCK-8 and BrdU cell proliferation ELISA, we have analyzed proliferative response of these cells to different antibodies. Results: We now show that a stimulating TSHR antibody was able to induce phosphorylation of the IGF-1R and initiate both TSHR and IGF-1R signaling in mouse and human fibroblasts. IGF-1R-B-mAb (1H7) inhibited all major IGF-1R signaling cascades and also reduced TSHR signaling. This resulted in the antibody-induced suppression of autophagy as shown by inhibition of multiple autophagy-related proteins (Beclin1, LC3a, LC3b, p62, and ULK1) and the induction of cell death by apoptosis as evidenced by activation of cleaved caspase 3, FADD, and caspase 8. Furthermore, this IGF-1R-blocking mAb suppressed serum-induced perkin and pink mitophagic proteins. Conclusions: Our observations clearly indicated that stimulating TSHR antibodies were able to enhance IGF-1R activity and contribute to retro-orbital cellular proliferation and inflammation. In contrast, an IGF-1R-B-mAb was capable of suppressing IGF-1R signaling leading to retro-orbital fibroblast/adipocyte death through the cell-extrinsic pathway of apoptosis. This is likely the major mechanism involved in proptosis reduction in patients with Graves' eye disease treated by IGF-1R inhibition.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Morshed SA, Ma R, Latif R, et al. Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition. Thyroid. 2022. PMID: 34927457. doi:10.1089/thy.2021.0176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。